Singh A - Search Results

1

Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.

Bhatti JS, Kaur S, Mishra J, Dibbanti H, Singh A, Reddy AP, Bhatti GK, Reddy PH. Bhatti JS, et al. Among authors: singh a. Biochim Biophys Acta Mol Basis Dis. 2023 Oct;1869(7):166798. doi: 10.1016/j.bbadis.2023.166798. Epub 2023 Jun 29. Biochim Biophys Acta Mol Basis Dis. 2023. PMID: 37392948 Free article. Review.

2

Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.

Rai SN, Singh C, Singh A, Singh MP, Singh BK. Rai SN, et al. Among authors: singh bk, singh c, singh a, singh mp. Mol Neurobiol. 2020 Jul;57(7):3075-3088. doi: 10.1007/s12035-020-01945-y. Epub 2020 May 27. Mol Neurobiol. 2020. PMID: 32462551 Review.

3

Zebrafish an experimental model of Huntington's disease: molecular aspects, therapeutic targets and current challenges.

Kumar V, Singh C, Singh A. Kumar V, et al. Among authors: singh c, singh a. Mol Biol Rep. 2021 Dec;48(12):8181-8194. doi: 10.1007/s11033-021-06787-y. Epub 2021 Oct 19. Mol Biol Rep. 2021. PMID: 34665402 Review.

4

The Role of Mitophagy in Various Neurological Diseases as a Therapeutic Approach.

Kaur S, Sharma N, Kumar V, Sharma D, Devi B, Kapil L, Singh C, Singh A. Kaur S, et al. Among authors: singh c, singh a. Cell Mol Neurobiol. 2023 Jul;43(5):1849-1865. doi: 10.1007/s10571-022-01302-8. Epub 2022 Nov 3. Cell Mol Neurobiol. 2023. PMID: 36326951 Review.

5

Modulating autophagy and mitophagy as a promising therapeutic approach in neurodegenerative disorders.

Mishra J, Bhatti GK, Sehrawat A, Singh C, Singh A, Reddy AP, Reddy PH, Bhatti JS. Mishra J, et al. Among authors: singh c, singh a. Life Sci. 2022 Dec 15;311(Pt A):121153. doi: 10.1016/j.lfs.2022.121153. Epub 2022 Nov 4. Life Sci. 2022. PMID: 36343743 Free PMC article. Review.

6

Role of Autophagy and Mitophagy in Neurodegenerative Disorders.

Kapil L, Kumar V, Kaur S, Sharma D, Singh C, Singh A. Kapil L, et al. Among authors: singh c, singh a. CNS Neurol Disord Drug Targets. 2024;23(3):367-383. doi: 10.2174/1871527322666230327092855. CNS Neurol Disord Drug Targets. 2024. PMID: 36974405

7

In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway.

Singh A, Kumar V, Langeh U, Kapil L, Kaur S, Rana N, Bhattacharya A, Singh R, Bhatti JS, Singh C. Singh A, et al. Among authors: singh c, singh r. J Mol Histol. 2024 Aug;55(4):599-625. doi: 10.1007/s10735-024-10217-1. Epub 2024 Jul 23. J Mol Histol. 2024. PMID: 39042217

8

Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective.

Kumar V, Kundu S, Singh A, Singh S. Kumar V, et al. Among authors: singh s, singh a. Curr Neuropharmacol. 2022;20(1):158-178. doi: 10.2174/1570159X19666210609160017. Curr Neuropharmacol. 2022. PMID: 34151764 Free PMC article. Review.

9

Coenzyme Q10 a mitochondrial restorer for various brain disorders.

Pradhan N, Singh C, Singh A. Pradhan N, et al. Among authors: singh c, singh a. Naunyn Schmiedebergs Arch Pharmacol. 2021 Nov;394(11):2197-2222. doi: 10.1007/s00210-021-02161-8. Epub 2021 Oct 1. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 34596729 Review.

10

Cellular and Mitochondrial Quality Control Mechanisms in Maintaining Homeostasis in Aging.

Langeh U, Kumar V, Kumar A, Kumar P, Singh C, Singh A. Langeh U, et al. Among authors: singh c, singh a. Rejuvenation Res. 2022 Oct;25(5):208-222. doi: 10.1089/rej.2022.0027. Epub 2022 Sep 20. Rejuvenation Res. 2022. PMID: 35850516 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,847 results

Search Page

Filters